Key result
Administration of 10% intravenous calcium gluconate prior to verapamil successfully converted paroxysmal supraventricular tachycardia to sinus rhythm in all attacks in infants.
Why the study?
Does intravenous calcium gluconate prior to verapamil prevent negative inotropic effects while maintaining antiarrhythmic efficacy in infants with paroxysmal supraventricular tachycardia?
Population
Infants with paroxysmal supraventricular tachycardia
Design
Case_series
Authors
Loading...
May support calcium pre-treatment to preserve verapamil efficacy in infant PSVT; hypothesis-generating and requires controlled trials before any practice consideration.
Case Report
Does intravenous calcium gluconate prior to verapamil prevent negative inotropic effects while maintaining antiarrhythmic efficacy in infants with paroxysmal supraventricular tachycardia?
Pre-treatment with intravenous calcium gluconate may prevent the negative inotropic effects of verapamil without compromising its efficacy in converting paroxysmal supraventricular tachycardia to sinus rhythm in infants.
Roguin et al. (1984) conducted a case report in Paroxysmal supraventricular tachycardia. Intravenous calcium gluconate prior to verapamil was evaluated on Conversion of supraventricular tachycardia to sinus rhythm. Administration of 10% intravenous calcium gluconate prior to verapamil successfully converted paroxysmal supraventricular tachycardia to sinus rhythm in all attacks in infants.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: